DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Colextran
Colextran
Classification of Medicinal Drugs and Driving: Co-Ordination and Synthesis Report
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
Development of Bile Acid Sequestrants Based on Cationic Hydrogels
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
2 12/ 35 74Al
Trends in Lipid-Modifying Agent Use in 83 Countries
Marrakesh Agreement Establishing the World Trade Organization
Adsorption of Sodium Cholate on Cationic Dextran Gels: Comparison of Isotherm Binding Models
Pharmaabkommen A1 E
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahr 2016
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Polymeric Bile Acid Sequestrants—Synthesis Using Conventional
Pharmaceutical Appendix to the Tariff Schedule 2
Customs Tariff - Schedule Xxi - 1
Accessibility Improving Information Using Online Patient Drug Reviews
Improving Information Accessibility Using Online Patient Drug Reviews
Top View
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark∗
Harmonized Tariff Schedule of the United States (2006) (Rev
In Vitro and in Vivo Evaluation of Novel Cross-Linked Saccharide Based Polymers As Bile Acid Sequestrants
Regulatory Change in Pharmaceutical Price: Evidence from A
Trends in Lipid-Modifying Agent Use in 83 Countries
Pharmaceutical Appendix to the Tariff Schedule 2
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
'Essays in Regulation of Pharmaceutical Markets'
Zbwleibniz-Informationszentrum
Lipid Modification Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease
Pharmaceutical Appendix to the Tariff Schedule 2
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
Non-Interventional Study Protocol
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Arzneimittel Richtwertvereinbarung Nach § 106B Abs
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri